Atlas Trials

Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)

Clinical trial NCT04530604 · COMPLETED

Trial details

NCT number
NCT04530604
Sponsor
Gregory Yanik
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVIDSars-CoV2COVID-19Acute Respiratory Distress Syndrome
Start date
2020-10-01
Primary completion
2021-03-26
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.